CATALOGO DEI PRODOTTI DELLA RICERCA

Merz, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.934
EU - Europa 1.816
AS - Asia 1.265
SA - Sud America 160
Continente sconosciuto - Info sul continente non disponibili 54
AF - Africa 41
OC - Oceania 5
Totale 5.275
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.885
RU - Federazione Russa 773
SG - Singapore 450
CN - Cina 372
IT - Italia 288
DE - Germania 174
GB - Regno Unito 153
VN - Vietnam 140
BR - Brasile 124
HK - Hong Kong 114
IE - Irlanda 85
FR - Francia 83
SE - Svezia 82
FI - Finlandia 62
KR - Corea 38
CA - Canada 36
BD - Bangladesh 31
IN - India 30
NL - Olanda 26
JP - Giappone 20
UA - Ucraina 16
AR - Argentina 15
AT - Austria 15
ES - Italia 12
TR - Turchia 12
PL - Polonia 10
ID - Indonesia 9
ZA - Sudafrica 9
BJ - Benin 8
NG - Nigeria 8
TG - Togo 8
IQ - Iraq 7
SA - Arabia Saudita 7
AU - Australia 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
MX - Messico 5
BE - Belgio 4
CH - Svizzera 4
JO - Giordania 4
LT - Lituania 4
PK - Pakistan 4
VE - Venezuela 4
CO - Colombia 3
DZ - Algeria 3
LB - Libano 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
UZ - Uzbekistan 3
AM - Armenia 2
AZ - Azerbaigian 2
CR - Costa Rica 2
GR - Grecia 2
IR - Iran 2
JM - Giamaica 2
KZ - Kazakistan 2
NP - Nepal 2
PY - Paraguay 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GI - Gibilterra 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 5.223
Salva come PNG Salva come JPEG
Città #
Moscow 312
Ashburn 309
Dallas 263
Singapore 259
Chandler 181
San Jose 170
Hong Kong 112
Southend 91
Dublin 86
Verona 74
Beijing 65
The Dalles 65
Munich 63
Council Bluffs 56
Ho Chi Minh City 52
Los Angeles 45
New York 38
Woodbridge 33
Jacksonville 32
Helsinki 30
Hanoi 25
Turku 25
Jinan 23
São Paulo 21
Buffalo 20
Lawrence 20
London 20
Princeton 20
Tianjin 20
Milan 19
Santa Clara 19
Wilmington 19
Frankfurt am Main 18
Rome 18
Atlanta 16
Tokyo 16
Orem 15
Toronto 15
Columbus 14
Taiyuan 14
Montreal 13
Sindelfingen 12
Changsha 11
Chicago 11
Seattle 11
Amsterdam 10
Bologna 10
Da Nang 10
Denver 10
Houston 10
Kent 10
Shenyang 10
Washington 10
Haikou 9
Nuremberg 9
Phoenix 9
Redondo Beach 9
Stockholm 9
Barnet 8
Cotonou 8
Hebei 8
Lomé 8
Marseille 8
Redwood City 8
Taizhou 8
Abuja 7
Hangzhou 7
Jakarta 7
Johannesburg 7
Monza 7
Paris 7
Trento 7
Vienna 7
Warsaw 7
Boston 6
Chennai 6
Madrid 6
Nanchang 6
Nanjing 6
Ningbo 6
Rio de Janeiro 6
San Francisco 6
Ann Arbor 5
Catania 5
City of London 5
Fairfield 5
Fuzhou 5
Guangzhou 5
Jiaxing 5
Mumbai 5
Nürnberg 5
Riyadh 5
Seoul 5
Treviso 5
Turin 5
Amman 4
Brasília 4
Brooklyn 4
Dhaka 4
Lappeenranta 4
Totale 3.148
Salva come PNG Salva come JPEG
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 322
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 297
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 259
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 239
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 236
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 209
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 207
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 195
Plasma Interleukin-8 is a biomarker for TAK1 activation and predicts resistance to nanoliposomal irinotecan in patients with gemcitabine-refractory pancreatic cancer 188
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer 182
Modulating TAK1 expression inhibits YAP and TAZ oncogenic functions in pancreatic cancer 177
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 176
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients 166
Targeting KRAS: The Elephant in the Room of Epithelial Cancers 165
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group 163
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion 158
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma 153
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer 149
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 144
Pemigatinib, a potent inhibitor of FGFRs for the treatment of cholangiocarcinoma 144
Electronic Medical Record-Assisted Telephone Follow-Up of Breast Cancer Survivors During the COVID-19 Pandemic: A Single Institution Experience 138
Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports 137
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 128
Population pharmacokinetics and exposure-overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer 123
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear 119
Safety and activity of the TGF beta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer 116
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study 107
Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials 107
Perioperative NALIRIFOX in Patients with Resectable Pancreatic Ductal Adenocarcinoma: An Updated Analysis of Survival and Response Biomarkers from the Phase II nITRO Trial. 104
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 90
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study 89
Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study 88
Totale 5.275
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.024
article - articoli 18.814
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 210
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.048
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022119 0 0 8 17 1 5 1 13 6 3 11 54
2022/2023492 25 67 34 79 38 130 3 26 64 8 12 6
2023/2024423 7 25 28 34 33 66 69 37 9 23 76 16
2024/2025816 40 37 38 127 30 34 62 40 86 42 112 168
2025/20262.698 144 114 256 413 670 187 268 123 227 181 48 67
2026/2027153 30 59 64 0 0 0 0 0 0 0 0 0
Totale 5.275